Response to Panagiotis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Response to Panagiotis

Published:2016-05-11 Issue:10 Volume:18 Page:1077-1078
ISSN:1524-6175
Container-title:The Journal of Clinical Hypertension
language:en
Short-container-title:J Clin Hypertens

Author:

Weinrauch Larry A.¹²³,Bayliss George¹⁴,Segal Alissa R.¹⁵,Liu Jiankang²³,Wisniewski Eric¹²³⁴,D'Elia John A.¹³

Affiliation:

1. Kidney and Hypertension Section; Joslin Diabetes Center; Boston MA

2. Clinical End Points Section; Cardiovascular Division; Brigham and Women's Hospital; Boston MA

3. Harvard Medical School; Boston MA

4. Division of Kidney Diseases and Hypertension; Rhode Island Hospital; Alpert Medical School; Brown University; Providence RI

5. MCPHS University; Boston MA

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jch.12839/fullpdf

Reference7 articles.

1. Therapeutic drug monitoring facilitates blood pressure control in resistant hypertension;Brinker;J Am Coll Cardiol,2014

2. The double challenge of resistant hypertension and chronic kidney disease;Rossignol;Lancet,2015

3. Can drugs work in patients who do not take them? The problem of non-adherence in resistant hypertension;Ruzicka;Curr Hypertens Rep,2015

4. Editorial: risk stratification of resistant hypertension in chronic kidney disease;Weinrauch;J Am Coll Cardiol,2013

5. Strategies for glucose control in a study population with diabetes, renal disease and anemia (TREAT study);Weinrauch;Diabetes Res Clin Pract,2016

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Susceptibility of ApoB and PCSK9 Genetic Polymorphisms to Diabetic Kidney Disease Among Chinese Diabetic Patients;Frontiers in Medicine;2021-04-06

2. Does diabetes impact therapeutic immunomodulation therapy decisions for kidney transplant recipients? Data from the Folic Acid for Vascular Outcome Reduction in Transplant (FAVORIT) trial;International Journal of Nephrology and Renovascular Disease;2017-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3